PATH Drug Solutions donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 17 -26,017 1,641,029 -8,607,315 -5,789,201 -3,999,080 -1,434,923 -1,166,151 -26,017 2,496,781 2,499,525 6,043,310 14,345,371 15,607,315
Global health 17 -26,017 1,641,029 -8,607,315 -5,789,201 -3,999,080 -1,434,923 -1,166,151 -26,017 2,496,781 2,499,525 6,043,310 14,345,371 15,607,315

Donation amounts by donor and year for donee PATH Drug Solutions

Donor Total 2018 2016 2015 2013 2012 2010 2009 2008
Bill and Melinda Gates Foundation (filter this donee) 27,897,499.17 -1,166,151.00 -6,539,262.00 -15,325,324.00 18,106,840.00 14,345,371.00 4,473,033.17 10,757,888.00 3,245,104.00
Total 27,897,499.17 -1,166,151.00 -6,539,262.00 -15,325,324.00 18,106,840.00 14,345,371.00 4,473,033.17 10,757,888.00 3,245,104.00

Full list of donations in reverse chronological order (17 donations)

DonorAmount (current USD)Amount rank (out of 17)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation-1,166,151.0072018-07-12Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish the viability, across development stages, of an injectable form of pre exposure prophylaxis (PrEP) as an intervention for HIV prevention within the portfolio of alternatives.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-1,434,923.0062016-02-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish the viability, across development stages, of an injectable form of pre exposure prophylaxis (PrEP) as an intervention for HIV prevention within the portfolio of alternatives.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-5,104,339.0032016-01-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish the viability, across development stages, of an injectable form of pre exposure prophylaxis (PrEP) as an intervention for HIV prevention within the portfolio of alternatives.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-2,718,929.0052015-08-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the development of a novel treatment for secretory diarrhea in infants and children in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-3,999,080.0042015-08-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build a portfolio of projects exploring potential anti-secretory drug targets in the gastrointestinal tract and develop drug candidate(s) to complement oral rehydration therapy (ORT); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-254,109.0082015-07-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to keep and build upon organizational capacity to further the work of the organization, especially in the Diarrhea/Enteric Diseases strategic area; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-5,789,201.0022015-07-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the development of a novel treatment for secretory diarrhea in infants and children in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation6,043,310.00142015-07-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support to PATH Drug Solutions. Drug Development (DRG) Core Grant. Investment start date: 7/22/2015 to end date: 11/17/2015. Grantee name: PATH Drug Solutions; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-8,607,315.0012015-07-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build a portfolio of projects exploring potential anti-secretory drug targets in the gastrointestinal tract and develop drug candidate(s) to complement oral rehydration therapy (ORT); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,499,525.00122013-10-28Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the development of a novel treatment for secretory diarrhea in infants and children in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation15,607,315.00172013-10-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build a portfolio of projects exploring potential anti-secretory drug targets in the gastrointestinal tract and develop drug candidate(s) to complement oral rehydration therapy (ORT); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation14,345,371.00162012-11-09Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish the viability, across development stages, of an injectable form of pre exposure prophylaxis (PrEP) as an intervention for HIV prevention within the portfolio of alternatives.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,499,050.00132010-11-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to keep and build upon organizational capacity to further the work of the organization, especially in the Diarrhea/Enteric Diseases strategic area; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-26,016.8392010-09-30Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to establish and validate a manufacturing process to make artemisinin-type drugs affordable for the world's poorest people; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation10,757,888.00152009-11-09Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for industrialization/scale-up of biosynthetic malaria drug. Industrialization/scale-up of biosynthetic malaria drug with Sanofi: Transition successful genetic platform organism to commercial fermentation scale-up with Sanofi Aventis for biosynthetic arte; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation2,496,781.00112008-11-21Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- for capacity building. Capacity Building and Organizational Effectiveness. Investment start date: 12/1/2008 to end date: 12/1/2009. Grantee name: PATH Drug Solutions; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation748,323.00102008-04-01Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct due diligence on Tribendimidine (an approved Chinese drug against hookworm infection), and to prepare a product development proposal to develop TBD, with the goal towards submission to and approval by a Western regulatory agency; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.